Newer continuous-flow left ventricular assist devices were linked to unacceptably high hospital readmission rates, which could limit their use in advanced heart failure care, researchers said. Study data showed cumulative incidences of hospital readmission were 34.6% at three months, 60.6% at six months and 84.6% at one year.
Newer LVAD has high readmission rates, study says
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|